Individuals interested in submitting an abstract for presentation during the conference must do so through the AACR Online Submission System below.
Log onto myAACR. If you are an AACR member, please use your AACR username and password. If you have forgotten either, you can look it up on the website by entering your Member ID. For non-AACR members, you will need to create a free myAACR account to submit your abstract.
Note: This is free and the account is not for membership to the AACR, only to submit your abstract.
Authors who submit abstracts confirm that they have not previously published these data, that they have not previously presented them at a large national annual scientific meeting, and that they are not planning to present or publish them prior to the dates of the 2021 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics conference. Each abstract should contain: (a) an introductory sentence indicating the purposes of the study; (b) a brief description of pertinent experimental procedures; (c) a summary of the new, unpublished data; and (d) a statement of the conclusions.
Please be sure to carefully check your abstract for content errors, spelling, names, etc. before submitting. The AACR does not proofread for or correct spelling, typographical, grammatical, or scientific errors, nor can changes be made once the abstract is submitted. If you have any questions or experience any problems, please contact AACR Abstract Support at [email protected].
Encore abstract submission guidelines
The 2021 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics conference will be accepting encore clinical trials presentations, including trials in progress (TiP). Authors must supply information regarding the original presentation, indicating the name of the meeting and publication number at the time of submission. The first author will be responsible for obtaining, and, upon request, showing proof that written permission has been obtained from the copyright holder of the original abstract publication(s). Encore TiP abstract submissions will be accepted for poster presentation only.
Encore submissions must:
- Have been presented solely in abstract form, including publication in conference proceedings.
- Include significant additional data from the previous presentation (as determined by the review committee).
- For TiP, continue to meet the necessary criteria.
Angiogenesis and antiangiogenesis agents
Apoptosis, necrosis, and autophagy
Biomarkers Cancer stem cells
Cell cycle regulators
Cellular responses to therapy
DNA repair and modulation
Drug metabolism, transport, and biodistribution
Drug resistance and modifiers
Epigenetic regulation of tumor immunity
Genomics, proteomics, and target discovery
Heat shock proteins
Hormonal agents and therapy
Immune mechanisms invoked by radiation therapy
Immune monitoring/clinical correlates
Immune response to therapies
In vitro and in vivo models for targets
Metastasis and invasion
Molecular classification of tumors
New molecular targets
Novel assay technology
Pediatric-early drug development
Pharmacogenetics, pharmacogenomics, and therapeutic response
Pharmacokinetics and pharmacodynamics
RNA and RNA-based technologies and therapies
Signal transduction modulators
Target identification and validation
Therapeutic agents: biological
Therapeutic agents: other
Therapeutic agents: small-molecule kinase inhibitors
Tumor immunology targets
FINANCIAL RELATIONSHIPS OF Meeting Presenters
NOTIFICATION OF ABSTRACT STATUS
All individuals listed as ABSTRACT PRESENTERS will be notified of acceptance or rejection by email approximately four weeks after the abstract submission deadline. Notices and instructions will be sent to the email address provided at the time of abstract submission. If an abstract is not selected for presentation, the presenter may request a full refund of the registration fee by contacting the AACR Meetings Department at [email protected].
PRESENTATION AND PUBLICATION
Accepted abstracts will be published as an online-only Proceedings supplement to an AACR journal after the completion of the meeting. Abstracts selected for presentation during the conference will be posted to the virtual conference platform. Every effort will be made to reproduce the content of the abstracts as submitted, except in certain circumstances where changes may be made to comply with AACR style. Abstract titles and authors will be posted on the AACR website on September 30 (only titles and authors; no data will be posted online before the conference). Details on the length and format of the presentations will be provided to individuals noted as ABSTRACT PRESENTERS of accepted abstracts. For programs that include short talks selected from the abstract submissions, instructions will be sent to the ABSTRACT PRESENTERS with the date, time, and format for those presentations.
Individuals planning on presenting an abstract at this conference are encouraged to register as early as possible. If an abstract is not accepted for presentation at the conference, the presenter may request a full refund of the registration fee. For additional information, please visit the registration page.
REQUEST FOR WITHDRAWAL
Once an abstract has been submitted, it may be withdrawn only by written request from the ABSTRACT PRESENTER. The request may be emailed to [email protected] and must be received by September 27.